Pulmonary and cardiovascular consequences of smoking

Clinics in Occupational and Environmental Medicine

Volumn 5, Issue 1, 2006, Pages 157-171

  Kamholz, Stephan L ^a,b,c,d  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; ORAL CONTRACEPTIVE AGENT;

ASTHMA; CANCER RISK; CARDIOVASCULAR DISEASE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; INCIDENCE; LUNG CARCINOMA; LUNG DISEASE; LUNG EMPHYSEMA; MORBIDITY; MORTALITY; PASSIVE SMOKING; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING; SMOKING CESSATION; SMOKING CESSATION PROGRAM; THROMBOEMBOLISM;

EID: 31644431947     PISSN: 15260046     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coem.2005.10.001     Document Type: Review

References (97)

1. S. De Flora F. D'Agostini R. Balansky A. Camoirano C. Bennicelli M. Bagnasco Modulation of cigarette smoke-related end-points in mutagenesis and carcinogenesis Mutat Res 523-524 2003 237-252 et al.
2. D.R. Patel D.N. Homnick Pulmonary effects of smoking Adolesc Med 11 2000 567-576
3. G.A. Thomas J. Rhodes J.T. Green C. Richardson Role of smoking in inflammatory bowel disease: Implications for therapy Postgrad Med J 76 2000 273-279
4. A. Zeidel B. Beilin I. Yardeni E. Mayburd G. Smirnov H. Bessler Immune response in asymptomatic smokers Acta Anaesthesiol Scand 46 2002 959-964
5. O. Balat A. Balat M.G. Ugur S. Pence The effect of smoking and caffeine on the fetus and placenta in pregnancy Clin Exp Obstet Gynecol 30 2003 57-59
6. S. Murin K.S. Bilello R. Matthay Other smoking-affected pulmonary diseases Clin Chest Med 21 2000 121-137
7. S.H. Kelder A. Prokhorov C.S. Barroso N. Murray P. Orpinas L. McCormick Smoking differences among African American, Hispanic and white middle school students in an urban setting Addict Behav 28 2003 513-522
8. T.J. Payne L. Diefenbach Characteristics of African American smokers: A brief review Am J Med Sci 326 2003 212-215
9. D. Lawrence J.E. Graber S.L. Mills H.I. Meissner R. Warnecke Smoking cessation interventions in US racial/ethnic minority populations: An assessment of the literature Prev Med 36 2003 204-216
10. E.D. Balbach R.J. Gasior E.M. Barbeau RJ Reynolds' targeting of African Americans: 1988-2000 Am J Public Health 93 2003 822-827
11. K. Fagerstrom The epidemiology of smoking: Health consequences and benefits of cessation Drugs 62 Suppl 2 2002 1-9
12. World Health Organization Tobacco Free Initiative: Global Data http://www.who.int/tobacco/en/atlas13.pdf Accessed November 30, 2003
13. S.D. Sullivan S.D. Ramsey T.A. Lee The economic burden of COPD Chest 117 Suppl 2 2000 5S-9S
14. E.L. Carmines Evaluation of the potential effects of ingredients added to cigarettes. Part 1: Cigarette design, testing approach, and review of results Food Chem Toxicol 40 2002 77-91
15. K. Rustemeier R. Stabbert H.J. Haussmann E. Roemer E.L. Carmines Evaluation of the potential effects of ingredients added to cigarettes. Part 2: Chemical composition of mainstream smoke Food Chem Toxicol 40 2002 93-104
16. E.T. Middleton A.H. Morice Breath carbon monoxide as an indication of smoking habit Chest 117 2000 758-763
17. G.P. Pfeifer M.F. Denissenko M. Olivier N. Tretyakova S.S. Hecht P. Hainaut Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers Oncogene 21 2002 7435-7451
18. H. Shen M.R. Spitz Y. Qiao Z. Guo L.E. Wang C.H. Bosken Smoking, DNA repair and risk of non-small cell lung cancer Int J Cancer 107 2003 84-88 et al.
19. A.M. Agius L.A. Smallman A.L. Pahor Age, smoking and nasal ciliary beat frequency Clin Otolaryngol 23 1998 227-230
20. F. Verra E. Escudier F. Lebargy J.F. Bernaudin H. DeCremoux J. Bignon Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers and nonsmokers Am J Respir Crit Care Med 151 3 Pt 1 1995 630-634
21. P.A. Kirkham G. Spooner C. Ffoulkes-Jones R. Calvez Cigarette smoke triggers macrophage adhesion and activation: Role of lipid peroxidation products and scavenger receptor Free Radic Biol Med 35 2003 697-710
22. M. Sockrider The respiratory effects of passive tobacco smoking Curr Opin Pulm Med 2 1996 129-133
23. R.C. Brownson M.C.R. Alavanja E.T. Hock T.S. Loy Passive smoking and lung cancer in nonsmoking women Am J Public Health 82 1992 1525-1530
24. Centers for Disease Control and Prevention State-specific prevalence of current cigarette smoking among adults, and policies and attitudes about secondhand smoke United States, 2000 MMWR Morb Mortal Wkly Rep 50 2001 1101-1106
25. R. Otsuka H. Watanabe K. Hirata K. Tokai T. Muro M. Yoshiyama Acute effects of passive smoking on the coronary circulation in healthy young adults JAMA 286 2001 436-441 et al.
26. S. Zevin S. Saunders S.G. Gourlay P. Jacob N.L. Benowitz Cardiovascular effects of carbon monoxide and cigarette smoking J Am Coll Cardiol 38 2001 1633-1638
27. S. Elsasser T. Mall M. Grossenbacher M. Zuber A.P. Perruchoud R. Ritz Influence of carbon monoxide (CO) on the early course of acute myocardial infarction Intensive Care Med 21 1995 716-722
28. D.P. Tashkin M.D. Altose J.E. Connett R.E. Kanner W.W. Lee R.A. Wise Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group Am J Respir Crit Care Med 153 6 Pt 1 1996 1802-1811
29. R.A. Wise R.E. Kanner P. Lindgren J.E. Connett M.D. Altose P.L. Enright The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: The Lung Health Study Chest 124 2003 449-458 et al.
30. D. Gorecka M. Bednarek A. Nowinski E. Puscinska A. Goljan-Geremek J. Zielinski Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate Chest 123 2003 1916-1923
31. M.N. Upton G. Davey Smith A. McConnachie C.L. Hart G.C. Watt Maternal and personal cigarette smoking synergize to increase airflow limitation in adults Am J Respir Crit Care Med 169 2004 479-487
32. K. Suzuki H. Tanaka S. Kaneko M. Nishi S. Teramoto S. Itoh Respiratory symptoms and cigarette smoking in 3,197 pulmonologist-based asthmatic patients with a highly prevalent use of inhaled corticosteroid J Asthma 40 2003 243-250 et al.
33. J.I. Jaen Diaz C. De Castro Mesa M.J. Gontan Garcia-Salamanca F. Lopez DeCastro Prevalence of chronic obstructive pulmonary disease and risk factors in smokers and ex-smokers Arch Bronconeumol 39 2003 554-558
34. A.Z. LaCroix G.S. Omenn Older adults and smoking Clin Geriatr Med 8 1992 69-87
35. N.J. Wald H.C. Watt Prospective study of effect of switching from cigarettes to pipe or cigars on mortality from three smoking related diseases BMJ 314 1997 1860-1863
36. R. Wilson C.F. Rayner Bronchitis Curr Opin Pulm Med 1 1995 177-182
37. R.A. Silverman E.D. Boudreaux P.G. Woodruff S. Clark C.A. Camargo Jr Cigarette smoking among asthmatic adults presenting to 64 emergency departments Chest 123 2003 1472-1479
38. M. Fraig U. Sreesha D. Savici A.L. Katzenstein Respiratory bronchiolitis: A clinicopathologic study in current smokers, ex-smokers and never smokers Am J Surg Pathol 26 2002 647-653
39. J.S. Park K.K. Brown R.M. Tuder V.A. Hale T.E. King Jr D.A. Lynch Respiratory-bronchiolitis associated interstitial lung disease: radiologic features with clinical and pathologic correlation J Comput Assist Tomogr 26 2002 13-20
40. R. Vassallo E.A. Jensen T.V. Colby J.H. Ryu W.W. Douglas T.E. Hartman The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic and functional correlations Chest 124 2003 1185-1187 et al.
41. T.E. King Jr Respiratory bronchiolitis-associated interstitial lung disease Clin Chest Med 14 1993 693-698
42. L.J. Kozak M.J. Hall M.F. Owings Division of Health Care Statistics National hospital discharge survey: 2000 annual summary with detailed diagnosis and procedure data Vital Health Stat Series 13 153 2002 1-8
43. B.M. Farr C.L. Bartlett J. Wadsworth D.L. Miller Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study Group Respir Med 94 2000 954-963
44. C.M. Luna A. Famiglietti R. Absi A.J. Videla F.J. Nogueira Fuenzalida A.D. Community-acquired pneumonia: Etiology, epidemiology, and outcome at a teaching hospital in Argentina Chest 118 2000 1344-1354 et al.
45. V. Kaplan D.C. Angus M.F. Griffin G. Clermont R. Scott Watson W.T. Linde-Zwirble Hospitalized community-acquired pneumonia in the elderly: age-and sex-related patterns of care and outcome in the United States Am J Respir Crit Care Med 165 2002 766-772
46. S. Murin K.S. Bilello R. Matthay Other smoking-affected pulmonary diseases Clin Chest Med 21 2000 121-137
47. S.R. Desai S.M. Ryan T.V. Colby Smoking-related interstitial lung diseases: Histopathologic and imaging perspectives Clin Radiol 58 2003 259-268
48. L.H. Youkeles J.N. Grizzanti Z. Liao C.J. Chang D.L. Rosenstreich Decreased tobacco-glycoprotein induced proliferation in vitro in pulmonary eosinophilic granuloma Am J Respir Crit Care Med 151 1996 145-150
49. A. Sudou T. Hashimoto H. Nakamura E. Hatao M. Ito F. Tsuchida Improvement of extrapulmonary lesions of eosinophilic granuloma after cessation of smoking Nihon Kokyuki Gakkai Zasshi 40 2002 326-330 et al.
50. V. Gajalakshmi R. Peto T.S. Kanaka P. Jha Smoking and mortality from tuberculosis and other diseases in India: Retrospective study of 43000 adult male deaths and 35000 controls Lancet 362 2003 1243-1244
51. A. Grobglas Smoking and oral contraceptives Contracept Fertil Sex (Paris) 4 1976 401-407
52. F. Fruzzetti F. De Negri M. Morale C. Ricci L. Ferrini C. Bersi Activation of coagulation in smoking and non-smoking women using a third-generation oral contraceptive containing desogestrel Eur J Contracept Reprod Health Care 4 1999 113-118 et al.
53. P.Y. Scarabin A.M. Vissac J.M. Kirzin P. Bourgeat J. Amiral R. Agher Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives -a preliminary report Thromb Haemost 82 1999 1112-1116 et al.
54. M. Barton R.K. Dubey T. Traupe Oral contraceptives and the risk of thrombosis and atherosclerosis Expert Opin Investig Drugs 11 2002 329-332
55. R.D. Farmer R.A. Lawrenson J.C. Todd T.J. Williams K.D. MacRae F. Tyrer A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives Br J Clin Pharmacol 49 2000 580-590 et al.
56. P.O. Hansson H. Eriksson L. Welin K. Svarsudd L. Wilhelmsen Smoking and abdominal obesity: Risk factors for venous thromboembolism among middle-aged men: The study of men born in 1913 Arch Intern Med 159 1999 1886-1890
57. P.B. Bach M.W. Kattan M.D. Thornquist M.G. Kris R.C. Tate M.J. Barnett Variations in lung cancer risk among smokers J Natl Cancer Inst 95 2003 470-478 et al.
58. M. Ezzati A.D. Lopez Estimates of global mortality attributable to smoking Lancet 362 2003 847-852
59. Centers for Disease Control and Prevention Cigarette smoking-attributable morbidity - United States, 2000 Morb Mortal Wkly Rep 52 2003 842-844
60. D. Ratschiller J. Heighway M. Gugger A. Kappeler F. Pirnia R.A. Schmid et al. Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival J Clin Oncol 21 2003 2085-2093
61. W. Zhou G. Liu D.P. Miller S.W. Thurston L.L. Xu J.C. Wain Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk Cancer Epidemiol Biomarkers Prev 12 2003 359-365 et al.
62. D. Gackowski E. Speina M. Zielinska J. Kowaleski R. Rozalski A. Siomek Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer Cancer Res 63 2003 4899-4902 et al.
63. T. Paz-Elizur M. Krupsky S. Blumenstein D. Elinger E. Schechtman Z. Livneh DNA repair activity for oxidative damage and risk of lung cancer J Natl Cancer Inst 95 2003 1312-1319
64. A. Lindgren E. Pukkala A. Nissinen J. Tuomilehto Blood pressure, smoking, and the incidence of lung cancer in hypertensive men in North Karelia, Finland Am J Epidemiol 158 2003 442-447
65. V. Westeel Diagnosis of lung cancer Rev Prat 53 2003 727-734
66. M.C. Boyars Clinical manifestations of carcinoma of the lung J Thorac Imaging 7 1991 21-28
67. R.D. Pugatch Radiologic evaluation in chest malignancies: A review of imaging modalities Chest 107 Suppl 6 1995 294S-297S
68. K.L. Murray E. Duvall D.M. Salter H. Monaghan Efficacy and pattern of use of sputum cytology as a diagnostic test Cytopathology 13 2002 350-354
69. D.M. Grzybicki T. Gross K.R. Geisinger S.S. Raab Estimation of performance and sequential selection of diagnostic tests in patients with lung lesions suspicious for cancer Arch Pathol Lab Med 126 2002 19-27
70. J.E. Dahlstrom G.M. Langdale-Smith D.T. James Fine needle aspiration cytology of pulmonary lesions: A reliable diagnostic test Pathology 33 2001 13-16
71. R.A. Schnoll M. Malstrom C. James R.L. Rothman S.M. Miller J.A. Ridge Correlates of tobacco use among smokers and recent quitters diagnosed with cancer Patient Educ Couns 46 2002 137-145 et al.
72. M. Kawahara S. Ushijima T. Kamimori N. Kodama M. Ogawara K. Matsui Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: The role of smoking cessation Br J Cancer 78 1998 409-412 et al.
73. C. Bolego A. Poli R. Paoletti Smoking and gender Cardiovasc Res 53 2002 568-576
74. B.V. Taylor G.Y. Oudit P.G. Kalman P. Liu Clinical and pathophysiological effects of active and passive smoking on the cardiovascular system Can J Cardiol 14 1998 1129-1139
75. S.A. Glantz W.W. Parmley Passive smoking and heart disease: Mechanisms and risk JAMA 273 1995 1047-1053
76. L.A. Bazzano J. He P. Muntner S. Vupputuri P.K. Whelton Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the Unites States Ann Intern Med 138 2003 891-897
77. S.W. Davies Clinical presentation and diagnosis of coronary artery disease: Stable angina Br Med Bull 59 2001 17-27
78. G. Gregoratos Clinical manifestations of acute myocardial infarction in older patients Am J Geriatr Cardiol 10 2001 345-347
79. C. Warlow C. Sudlow M. Dennis J. Wardlaw P. Sandercock Stroke Lancet 362 2003 1211-1224
80. G.J. Hankey Smoking and risk of stroke J Cardiovasc Risk 6 1999 207-211
81. T. Kurth C.S. Kase K. Berger J.M. Gaziano N.R. Cook J.E. Buring Smoking and risk of hemorrhagic stroke in women Stroke 34 2003 2792-2795
82. M. Lorberboym Y. Lampl M. Sadeh Correlation of (99m)Tc-DTPA SPECT of the blood-brain barrier with neurologic outcome after acute stroke J Nucl Med 44 2003 1898-1904
83. A.R. Xavier A.I. Qureshi J.F. Kirmani A.M. Yahia R. Bakshi Neuroimaging of stroke: A review South Med J 96 2003 367-379
84. E.A. Murphy M.S. Danna-Lopes I. Sarfati S.K. Rao J.R. Cohen Nicotine-stimulated elastase activity release by neutrophils in patients with abdominal aortic aneurysms Ann Vasc Surg 12 1998 41-45
85. J.S. Lindholt B. Jorgensen N.A. Klitgaard E.W. Henneberg Systemic levels of cotinine and elastase, but not pulmonary function, are associated with the progression of small abdominal aortic aneurysms Eur J Endovasc Surg 26 2003 418-422
86. F.A. Lederle D.B. Nelson A.M. Joseph Smoker's relative risk for aortic aneurysm compared with other smoking-related diseases: A systematic review J Vasc Surg 38 2003 329-334
87. O. Auerbach L. Garfinkel Atherosclerosis and aneurysm of aorta in relation to smoking habits and age Chest 78 1980 805-809
88. J.S. Lindholt N.H. Heegaard S. Vammen H. Fasting E.W. Henneberg L. Heickendorff Smoking, but not lipids, lipoprotein(a) and antibodies against oxidized LDL, is correlated to the expansion of abdominal aortic aneurysms Eur J Vasc Endovasc Surg 21 2001 51-56
89. M.H. Criqui Peripheral arterial disease: Epidemiologic aspects Vasc Med 6 Suppl 3 2001 3-7
90. S. Novo Classiffication, epidemiology, risk factors, and natural history of peripheral arterial disease Diabetes Obes Metab 4 Suppl 2 2002 S1-S6
91. C. Cimminiello PAD: Epidemiology and pathophysiology Thromb Res 106 2002 V295-V301
92. B. Fowler K. Jamrozik P. Norman Y. Allen Prevalence of peripheral arterial disease: Persistence of excess risk in former smokers Aust N Z J Public Health 26 2002 219-224
93. S. Barretto K.V. Ballman T.W. Rooke I.J. Kullo Early-onset peripheral arterial occlusive disease: Clinical features and determinants of disease severity and location Vasc Med 8 2003 95-100
94. S. Tatli M.J. Lipton B.D. Davison R.B. Skorstad E.K. Yucel From the rSNA refresher courses: MR imaging of aortic and peripheral vascular disease Radiographics 23 Spec No 2003 S59-S78
95. K. Visser J.L. Bosch T. Leinert J.M. van Engelshoven Jr J. Passchier M.G. Hunink Patients' preferences for MR angiography and duplex US in the work-up of peripheral arterial disease Eur J Vasc Endovasc Surg 26 2003 537-543
96. S. Gourgou F. Dedieu H. Sancho-Garnier Lower limb venous insufficiency and tobacco smoking Am J Epidemiol 155 2002 1007-1015
97. American Society of Clinical Oncology American Society of Clinical Oncology: Policy stTtement update: tobacco-control - reducing cancer incidence and savings lives J Clin Oncol 21 2003 2777-2786